Loading…

The natural course of chronic hepatitis C: implications for clinical practice

Hepatitis C is an important public health problem with high rates of chronic infection ensuing after viral acquisition. The spectrum of the disease ranges from mild to severe chronic hepatitis, cirrhosis and hepatocellular carcinoma. Extra‐hepatic manifestations may occur. The disease is complex and...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of viral hepatitis 1998-09, Vol.5 (s1), p.9-12
Main Author:	Dusheiko, G. M.
Format:	Article
Language:	English
Subjects:	Age Factors Alanine Transaminase - blood Biopsy cirrhosis Disease Progression Europe Fibrosis Hepacivirus - immunology hepatitis C Hepatitis C virus Hepatitis C, Chronic - complications Hepatitis C, Chronic - pathology Humans Liver - pathology Liver Cirrhosis - etiology Liver Cirrhosis - pathology Liver Cirrhosis - surgery natural history Population Surveillance
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by	cdi_FETCH-LOGICAL-c5642-86151674175d716cdd4c1ae607279365bea089be20095fb82f9c380a1083ab43
cites
container_end_page	12
container_issue	s1
container_start_page	9
container_title	Journal of viral hepatitis
container_volume	5
creator	Dusheiko, G. M.
description	Hepatitis C is an important public health problem with high rates of chronic infection ensuing after viral acquisition. The spectrum of the disease ranges from mild to severe chronic hepatitis, cirrhosis and hepatocellular carcinoma. Extra‐hepatic manifestations may occur. The disease is complex and predictions about long‐term prognosis for individual patients remain difficult. It is generally accepted that 10–20% of patients with chronic hepatitis C will develop cirrhosis within 10 years of first infection: identifying the group of patients at greatest risk remains a primary challenge for clinicians. Older age of infection, duration of infection, degree of liver inflammation at first biopsy and cofactors such as alcohol abuse, all appear to be predictors of a poorer prognosis. The following paper aims to identify some of the features of the natural history of hepatitis C most relevant to the clinician.
doi_str_mv	10.1046/j.1365-2893.1998.0050s1009.x
format	article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70017206</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70017206</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5642-86151674175d716cdd4c1ae607279365bea089be20095fb82f9c380a1083ab43</originalsourceid><addsrcrecordid>eNqVkE1v2yAYx1G1quvLPkIlDtNudh_AgJl22JQ1fUu3S7QeESZYIXNiF2w1_fbFSpRr1ROg_8vD80PoK4GcQCGuVjlhgme0VCwnSpU5AIdIAFS-PUKnB_HTeOc0S2rxGZ3FuAIgjHJygk6UVFxRdooe50uHN6YfgmmwbYcQHW5rbJeh3XiLl64zve99xJPv2K-7xtv0bjcR123AtvHJlIJdMLb31l2g49o00X3Zn-doPr2eT26z2d-bu8mvWWa5KGhWCsKJkAWRfCGJsItFYYlxAiSVKn2_cgZKVTmaduJ1VdJaWVaCIVAyUxXsHH3b1XahfR5c7PXaR-uaxmxcO0Qt06KSgnjXmFyFZKxMxh87ow1tjMHVugt-bcKrJqBH6nqlR7B6BKtH6vpAXW9T_HI_Z6jWbnEI7zEn_edOf_GNe_1Qt77_dwtAU0W2q_Cxd9tDhQn_tZBMcv3050YXTzP--_5hqqfsDY6ZoBM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17247338</pqid></control><display><type>article</type><title>The natural course of chronic hepatitis C: implications for clinical practice</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Dusheiko, G. M.</creator><creatorcontrib>Dusheiko, G. M.</creatorcontrib><description>Hepatitis C is an important public health problem with high rates of chronic infection ensuing after viral acquisition. The spectrum of the disease ranges from mild to severe chronic hepatitis, cirrhosis and hepatocellular carcinoma. Extra‐hepatic manifestations may occur. The disease is complex and predictions about long‐term prognosis for individual patients remain difficult. It is generally accepted that 10–20% of patients with chronic hepatitis C will develop cirrhosis within 10 years of first infection: identifying the group of patients at greatest risk remains a primary challenge for clinicians. Older age of infection, duration of infection, degree of liver inflammation at first biopsy and cofactors such as alcohol abuse, all appear to be predictors of a poorer prognosis. The following paper aims to identify some of the features of the natural history of hepatitis C most relevant to the clinician.</description><identifier>ISSN: 1352-0504</identifier><identifier>EISSN: 1365-2893</identifier><identifier>DOI: 10.1046/j.1365-2893.1998.0050s1009.x</identifier><identifier>PMID: 9795923</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Age Factors ; Alanine Transaminase - blood ; Biopsy ; cirrhosis ; Disease Progression ; Europe ; Fibrosis ; Hepacivirus - immunology ; hepatitis C ; Hepatitis C virus ; Hepatitis C, Chronic - complications ; Hepatitis C, Chronic - pathology ; Humans ; Liver - pathology ; Liver Cirrhosis - etiology ; Liver Cirrhosis - pathology ; Liver Cirrhosis - surgery ; natural history ; Population Surveillance</subject><ispartof>Journal of viral hepatitis, 1998-09, Vol.5 (s1), p.9-12</ispartof><rights>1998 Blackwell Science Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5642-86151674175d716cdd4c1ae607279365bea089be20095fb82f9c380a1083ab43</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9795923$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dusheiko, G. M.</creatorcontrib><title>The natural course of chronic hepatitis C: implications for clinical practice</title><title>Journal of viral hepatitis</title><addtitle>J Viral Hepat</addtitle><description>Hepatitis C is an important public health problem with high rates of chronic infection ensuing after viral acquisition. The spectrum of the disease ranges from mild to severe chronic hepatitis, cirrhosis and hepatocellular carcinoma. Extra‐hepatic manifestations may occur. The disease is complex and predictions about long‐term prognosis for individual patients remain difficult. It is generally accepted that 10–20% of patients with chronic hepatitis C will develop cirrhosis within 10 years of first infection: identifying the group of patients at greatest risk remains a primary challenge for clinicians. Older age of infection, duration of infection, degree of liver inflammation at first biopsy and cofactors such as alcohol abuse, all appear to be predictors of a poorer prognosis. The following paper aims to identify some of the features of the natural history of hepatitis C most relevant to the clinician.</description><subject>Age Factors</subject><subject>Alanine Transaminase - blood</subject><subject>Biopsy</subject><subject>cirrhosis</subject><subject>Disease Progression</subject><subject>Europe</subject><subject>Fibrosis</subject><subject>Hepacivirus - immunology</subject><subject>hepatitis C</subject><subject>Hepatitis C virus</subject><subject>Hepatitis C, Chronic - complications</subject><subject>Hepatitis C, Chronic - pathology</subject><subject>Humans</subject><subject>Liver - pathology</subject><subject>Liver Cirrhosis - etiology</subject><subject>Liver Cirrhosis - pathology</subject><subject>Liver Cirrhosis - surgery</subject><subject>natural history</subject><subject>Population Surveillance</subject><issn>1352-0504</issn><issn>1365-2893</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqVkE1v2yAYx1G1quvLPkIlDtNudh_AgJl22JQ1fUu3S7QeESZYIXNiF2w1_fbFSpRr1ROg_8vD80PoK4GcQCGuVjlhgme0VCwnSpU5AIdIAFS-PUKnB_HTeOc0S2rxGZ3FuAIgjHJygk6UVFxRdooe50uHN6YfgmmwbYcQHW5rbJeh3XiLl64zve99xJPv2K-7xtv0bjcR123AtvHJlIJdMLb31l2g49o00X3Zn-doPr2eT26z2d-bu8mvWWa5KGhWCsKJkAWRfCGJsItFYYlxAiSVKn2_cgZKVTmaduJ1VdJaWVaCIVAyUxXsHH3b1XahfR5c7PXaR-uaxmxcO0Qt06KSgnjXmFyFZKxMxh87ow1tjMHVugt-bcKrJqBH6nqlR7B6BKtH6vpAXW9T_HI_Z6jWbnEI7zEn_edOf_GNe_1Qt77_dwtAU0W2q_Cxd9tDhQn_tZBMcv3050YXTzP--_5hqqfsDY6ZoBM</recordid><startdate>199809</startdate><enddate>199809</enddate><creator>Dusheiko, G. M.</creator><general>Blackwell Science Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>199809</creationdate><title>The natural course of chronic hepatitis C: implications for clinical practice</title><author>Dusheiko, G. M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5642-86151674175d716cdd4c1ae607279365bea089be20095fb82f9c380a1083ab43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Age Factors</topic><topic>Alanine Transaminase - blood</topic><topic>Biopsy</topic><topic>cirrhosis</topic><topic>Disease Progression</topic><topic>Europe</topic><topic>Fibrosis</topic><topic>Hepacivirus - immunology</topic><topic>hepatitis C</topic><topic>Hepatitis C virus</topic><topic>Hepatitis C, Chronic - complications</topic><topic>Hepatitis C, Chronic - pathology</topic><topic>Humans</topic><topic>Liver - pathology</topic><topic>Liver Cirrhosis - etiology</topic><topic>Liver Cirrhosis - pathology</topic><topic>Liver Cirrhosis - surgery</topic><topic>natural history</topic><topic>Population Surveillance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dusheiko, G. M.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of viral hepatitis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dusheiko, G. M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The natural course of chronic hepatitis C: implications for clinical practice</atitle><jtitle>Journal of viral hepatitis</jtitle><addtitle>J Viral Hepat</addtitle><date>1998-09</date><risdate>1998</risdate><volume>5</volume><issue>s1</issue><spage>9</spage><epage>12</epage><pages>9-12</pages><issn>1352-0504</issn><eissn>1365-2893</eissn><abstract>Hepatitis C is an important public health problem with high rates of chronic infection ensuing after viral acquisition. The spectrum of the disease ranges from mild to severe chronic hepatitis, cirrhosis and hepatocellular carcinoma. Extra‐hepatic manifestations may occur. The disease is complex and predictions about long‐term prognosis for individual patients remain difficult. It is generally accepted that 10–20% of patients with chronic hepatitis C will develop cirrhosis within 10 years of first infection: identifying the group of patients at greatest risk remains a primary challenge for clinicians. Older age of infection, duration of infection, degree of liver inflammation at first biopsy and cofactors such as alcohol abuse, all appear to be predictors of a poorer prognosis. The following paper aims to identify some of the features of the natural history of hepatitis C most relevant to the clinician.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>9795923</pmid><doi>10.1046/j.1365-2893.1998.0050s1009.x</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 1352-0504
ispartof	Journal of viral hepatitis, 1998-09, Vol.5 (s1), p.9-12
issn	1352-0504 1365-2893
language	eng
recordid	cdi_proquest_miscellaneous_70017206
source	Wiley-Blackwell Read & Publish Collection
subjects	Age Factors Alanine Transaminase - blood Biopsy cirrhosis Disease Progression Europe Fibrosis Hepacivirus - immunology hepatitis C Hepatitis C virus Hepatitis C, Chronic - complications Hepatitis C, Chronic - pathology Humans Liver - pathology Liver Cirrhosis - etiology Liver Cirrhosis - pathology Liver Cirrhosis - surgery natural history Population Surveillance
title	The natural course of chronic hepatitis C: implications for clinical practice
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T04%3A37%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20natural%20course%20of%20chronic%20hepatitis%20C:%20implications%20for%20clinical%20practice&rft.jtitle=Journal%20of%20viral%20hepatitis&rft.au=Dusheiko,%20G.%20M.&rft.date=1998-09&rft.volume=5&rft.issue=s1&rft.spage=9&rft.epage=12&rft.pages=9-12&rft.issn=1352-0504&rft.eissn=1365-2893&rft_id=info:doi/10.1046/j.1365-2893.1998.0050s1009.x&rft_dat=%3Cproquest_cross%3E70017206%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5642-86151674175d716cdd4c1ae607279365bea089be20095fb82f9c380a1083ab43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17247338&rft_id=info:pmid/9795923&rfr_iscdi=true